Beyond the tip of the iceberg: A narrative review to identify research gaps on comorbid psychiatric disorders in adolescents with methamphetamine use disorder or chronic methamphetamine use

References

• Buck JM, Siegel JA. The effects of adolescent methamphetamine exposure. Front Neurosci. 2015;9(151):151.
   PubMedGoogle Scholar
• Marshall BD, Werb D. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction. 2010;105(6):991–1002.
   PubMed Web of Science ®Google Scholar
• UNODOC. World Drug Report 2019 (United Nations publication, Sales No. E.19.XI.9). Vienna, Austria: United Nations Office on Drugs and Crime; 2019.
   Google Scholar
• Yen CF, Yang YH, Chong MY. Correlates of methamphetamine use for Taiwanese adolescents. Psychiatry Clin Neurosci. 2006;60(2):160–167.
   PubMed Web of Science ®Google Scholar
• Zhuang SM, Chen F. Chinese adolescents and youth with methamphetamine dependence: prevalence and concurrent psychological problems. Nurs Res. 2016;65(2):117–124.
   PubMed Web of Science ®Google Scholar
• Sutcliffe CG, German D, Sirirojn B, et al. Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand. Drug Alcohol Depend. 2009;101(3):146–151.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Ozaki S, Kobayashi O, Wada K. Current situation and clinical characteristics of sedative-related disorder patients in Japan: comparison with methamphetamine-related disorder patients. Act Nerv Super. 2015;57(1):12–28.
   Google Scholar
• Degenhardt L, Coffey C, Moran P, Carlin JB, Patton GC. The predictors and consequences of adolescent amphetamine use: findings from the Victoria Adolescent Health Cohort Study. Addiction. 2007;102(7):1076–1084.
   PubMed Web of Science ®Google Scholar
• McKetin R, McLaren J, Kelly E. The Sydney methamphetamine market: patterns of supply, use, personal harms and social consequences. In: National Drug Law Enforcement Research Fund Monograph, ed. Monograph Series, no. 13. Adelaide: Australian Centre for Policing Studies; 2005.
   Google Scholar
• Ling W, Rawson R, Shoptaw S, Ling W. Management of methamphetamine abuse and dependence. Curr Psychiatry Rep. 2006;8(5):345–354.
   PubMedGoogle Scholar
• Herbeck DM, Brecht ML, Lovinger K. Mortality, causes of death, and health status among methamphetamine users. J Addict Dis. 2015;34(1):88–100.
   PubMed Web of Science ®Google Scholar
• Chen LY, Strain EC, Alexandre PK, Alexander GC, Mojtabai R, Martins SS. Correlates of nonmedical use of stimulants and methamphetamine use in a national sample. Addict Behav. 2014;39(5):829–836.
   PubMed Web of Science ®Google Scholar
• Berg MK, Hobkirk AL, Joska JA, Meade CS. The role of substance use coping in the relation between childhood sexual abuse and depression among methamphetamine users in South Africa. Psychol Trauma. 2017;9(4):493–499.
   PubMed Web of Science ®Google Scholar
• Arnaud N, Thomasius R. Methamphetamine: epidemiology, clinical importance and sequelae of abuse. Nervenarzt. 2017;88(9):1079–1090.
   PubMed Web of Science ®Google Scholar
• Milin S, Lotzin A, Degkwitz P, Verthein U, Schäfer I. Amphetamin und Methamphetamin - Personengruppen mit missbräuchlichem Konsum und Ansatzpunkte für präventive Maßnahmen. Hamburg: Zentrum für Interdisziplinäre Suchtforschung (ZIS) der Universität Hamburg; 2014.
   Google Scholar
• Mravčík V, Skařupová K, Orlíková B, Zábranský T, Karachaliou K, Schulte B. Use of gelatine capsules for application of methamphetamine: a new harm reduction approach. Int J Drug Policy. 2011;22(2):172–173.
   PubMed Web of Science ®Google Scholar
• Luikinga SJ, Kim JH, Perry CJ. Developmental perspectives on methamphetamine abuse: exploring adolescent vulnerabilities on brain and behavior. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87(Pt A):78–84.
   PubMedGoogle Scholar
• Reiter AM, Deserno L, Wilbertz T, Heinze HJ, Schlagenhauf F. Risk factors for addiction and their association with model-based behavioral control. Front Behav Neurosci. 2016;10:26.
   PubMed Web of Science ®Google Scholar
• Pfeiffer-Gerschel T, Schneider F, Dammer E, Braun B, Kraus L. Methamphetaminkonsum in Deutschland: Verbreitung und Problemlage. Sucht. 2019;65(4):241–249.
   Google Scholar
• Springer AE, Peters RJ, Shegog R, White DL, Kelder SH. Methamphetamine use and sexual risk behaviors in US High school students: findings from a national risk behavior survey. Prev Sci. 2007;8(2):103–113.
   PubMed Web of Science ®Google Scholar
• Johnston LD, Miech RA, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME. Monitoring the Future National Survey Results on Drug Use 1975-2018: Overview, Key Findings on Adolescent Drug Use. Ann Arbor, MI: Institute for Social Research, University of Michigan; 2019.
   Google Scholar
• Wittchen H-U, Behrendt S, Höfler M, et al. What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention. Int J Methods Psychiatr Res. 2008;17(S1):S16–S29.
   PubMedGoogle Scholar
• Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153–160.
   PubMed Web of Science ®Google Scholar
• Cohen JB, Dickow A, Horner K, et al. Abuse and violence history of men and women in treatment for methamphetamine dependence. Am J Addict. 2003;12(5):377–385.
   PubMed Web of Science ®Google Scholar
• Pluddemann A, Flisher AJ, McKetin R, Parry C, Lombard C. Methamphetamine use, aggressive behavior and other mental health issues among high-school students in Cape Town, South Africa. Drug Alcohol Depend. 2010;109(1–3):14–19.
   PubMed Web of Science ®Google Scholar
• Sexton RL, Carlson RG, Leukefeld CG, Booth BM. Methamphetamine use and adverse consequences in the rural southern United States: an ethnographic overview. J Psychoact Drugs. 2006;38(sup3):393–404.
   Google Scholar
• Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253–262.
   PubMed Web of Science ®Google Scholar
• Sommers I, Baskin D, Baskin-Sommers A. Methamphetamine use among young adults: health and social consequences. Addict Behav. 2006;31(8):1469–1476.
   PubMed Web of Science ®Google Scholar
• Smith LM, Paz MS, LaGasse LL, et al. Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study. Depress Anxiety. 2012;29(6):515–522.
   PubMed Web of Science ®Google Scholar
• Nicosia N, Liccardo Pacula R, Kilmer B, Lundberg R, Chiesa J. The economic cost of methamphetamine use in the United States, 2005. https://www.rand.org/content/dam/rand/pubs/monographs/2009/RAND_MG829.pdf. Published 2005.
   Google Scholar
• Tait RJ, Whetton S, Shanahan M, et al. Quantifying the societal cost of methamphetamine use to Australia. Int J Drug Policy. 2018;62:30–36.
   PubMed Web of Science ®Google Scholar
• Chen CK, Lin SK, Sham PC, et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med. 2003;33(8):1407–1414.
   PubMed Web of Science ®Google Scholar
• Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–773.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Boyle M. Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry. 2018;175(8):729–740.
   PubMed Web of Science ®Google Scholar
• Verdejo-Garcia A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32(4):777–810.
   PubMed Web of Science ®Google Scholar
• Cox WM, Klinger E. Motivational structure. Relationships with substance use and processes of change. Addict Behav. 2002;27(6):925–940.
   PubMed Web of Science ®Google Scholar
• Simons J, Correia CJ, Carey KB. A comparison of motives for marijuana and alcohol use among experienced users. Addict Behav. 2000;25(1):153–160.
   PubMed Web of Science ®Google Scholar
• Hartwell KJ, Johnson RH, McRae-Clark AL, et al. Motives for using: a comparison of prescription opioid, marijuana and cocaine dependent individuals. Am J Addict. 2012;21(4):390–391.
   Web of Science ®Google Scholar
• Thurn D, Kuntsche E, Weber JA, Wolstein J. Development and validation of the amphetamine-type stimulants motive questionnaire in a clinical population. Front Psychiatry. 2017;8:183–183.
   PubMed Web of Science ®Google Scholar
• Milin S, Kleinau C, Ludorf T, et al. Motives for illicit stimulant use a comparison of amphetamine and methamphetamine users. Suchttherapie. 2016;17(1):17–21.
   Web of Science ®Google Scholar
• Gouzoulis-Mayfrank E, Daumann J. Neurotoxicity of drugs of abuse–the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines. Dialogues Clin Neurosci. 2009;11(3):305–317.
   PubMedGoogle Scholar
• McKetin R, Dawe S, Burns RA, et al. The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug Alcohol Depend. 2016;161:104–109.
   PubMed Web of Science ®Google Scholar
• McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction. 2005;100(9):1320–1329.
   PubMed Web of Science ®Google Scholar
• Nakama H, Chang L, Cloak C, Jiang C, Alicata D, Haning W. Association between psychiatric symptoms and craving in methamphetamine users. Am J Addict. 2008;17(5):441–446.
   PubMed Web of Science ®Google Scholar
• Warden D, Sanchez K, Greer T, et al. Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders. Psychiatry Res. 2016;246:136–141.
   PubMed Web of Science ®Google Scholar
• Angelo FN, McDonell MG, Lewin MR, et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug Alcohol Depend. 2013;131(1–2):162–165.
   PubMed Web of Science ®Google Scholar
• Brecht ML, Herbeck D. Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug Alcohol Depend. 2014;139:18–25.
   PubMed Web of Science ®Google Scholar
• Salo R, Flower K, Kielstein A, Leamon MH, Nordahl TE, Galloway GP. Psychiatric comorbidity in methamphetamine dependence. Psychiatry Res. 2011;186(2–3):356–361.
   PubMed Web of Science ®Google Scholar
• Weich L, Pienaar W. Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa. Afr J Psychiatry (Johannesbg). 2009;12(3):213–217.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Yen CF, Chong MY. Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study. Compr Psychiatry. 2006;47(3):215–220.
   PubMed Web of Science ®Google Scholar
• McKetin R, Ross J, Kelly E, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev. 2008;27(3):277–285.
   PubMed Web of Science ®Google Scholar
• Farnia V, Bagher Mousavi S, Tatari F, et al. Prevalence of childhood attention-deficit/hyperactivity disorder (ADHD) in methamphetamine dependence: a descriptive study. Iran J Psychiatry Behav Sci. 2018;12(4):e61329.
   Web of Science ®Google Scholar
• Matsumoto T, Kamijo A, Yamaguchi A, Iseki E, Hirayasu Y. Childhood histories of attention-deficit hyperactivity disorders in Japanese methamphetamine and inhalant abusers: preliminary report. Psychiatry Clin Neurosci. 2005;59(1):102–105.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Yamaguchi A, Asami T, et al. Drug preferences in illicit drug abusers with a childhood tendency of attention deficit/hyperactivity disorder: a study using the Wender Utah Rating Scale in a Japanese prison. Psychiatry Clin Neurosci. 2005;59(3):311–318.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun Y, Yu Z, et al. Risk factors and an early prediction model for persistent methamphetamine-related psychiatric symptoms. Addict Biol. 2020;25(1):e12709.
   PubMed Web of Science ®Google Scholar
• Luderer M, Kiefer F, Reif A, Moggi FA. ADHD in adult patients with substance use disorders. Nervenarzt. 2019;90(9):926–931.
   PubMed Web of Science ®Google Scholar
• Crunelle CL, van den Brink W, Moggi F, et al. International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder. Eur Addict Res. 2018;24(1):43–51.
   PubMed Web of Science ®Google Scholar
• King G, Alicata D, Cloak C, Chang L. Psychiatric symptoms and HPA axis function in adolescent methamphetamine users. J Neuroimmune Pharmacol. 2010;5(4):582–591.
   PubMed Web of Science ®Google Scholar
• Auerbach RP, Mortier P, Bruffaerts R, et al. WHO world mental health surveys international college student project: prevalence and distribution of mental disorders. J Abnorm Psychol. 2018;127(7):623–638.
   PubMed Web of Science ®Google Scholar
• Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 1996;91(1):81–87.
   PubMed Web of Science ®Google Scholar
• Zweben JE, Cohen JB, Christian D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004;13(2):181–190.
   PubMed Web of Science ®Google Scholar
• Wada K, Fukui S. [Relationship between years of methamphetamine use and symptoms of methamphetamine psychosis. Arukoru Kenkyuto Yakubutsu Ison. 1990;25(3):143–158.
   PubMedGoogle Scholar
• Topp L, Mattick RP. Validation of the amphetamine dependence syndrome and the SAmDQ. Addiction. 1997;92(2):151–162.
   PubMed Web of Science ®Google Scholar
• Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs. 2000;32(2):137–141.
   PubMed Web of Science ®Google Scholar
• Wang DS, Zhou CL, Chang YK. Acute exercise ameliorates craving and inhibitory deficits in methamphetamine: an ERP study. Physiol Behav. 2015;147:38–46.
   PubMed Web of Science ®Google Scholar
• Sattah MV, Supawitkul S, Dondero TJ, et al. Prevalence of and risk factors for methamphetamine use in northern Thai youth: results of an audio-computer-assisted self-interviewing survey with urine testing. Addiction. 2002;97(7):801–808.
   PubMed Web of Science ®Google Scholar
• Rawson RA, Gonzales R, Obert JL, McCann MJ, Brethen P. Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response. J Subst Abuse Treat. 2005;29(2):67–74.
   PubMed Web of Science ®Google Scholar
• Yen CF, Su YC. The associations of early-onset methamphetamine use with psychiatric morbidity among Taiwanese adolescents. Subst Use Misuse. 2006;41(1):35–44.
   PubMed Web of Science ®Google Scholar
• Semple SJ, Zians J, Strathdee SA, Patterson TL. Psychosocial and behavioral correlates of depressed mood among female methamphetamine users. J Psychoact Drugs. 2007;39(sup4):353–366.
   Google Scholar
• Lin S-K, Ball D, Hsiao C-C, Chiang Y-L, Ree S-C, Chen C-K. Psychiatric comorbidity and gender differences of persons incarcerated for methamphetamine abuse in Taiwan. Psychiatry Clin Neurosci. 2004;58(2):206–212.
   PubMed Web of Science ®Google Scholar
• Harkness KL, Stewart JG, Wynne-Edwards KE. Cortisol reactivity to social stress in adolescents: role of depression severity and child maltreatment. Psychoneuroendocrinology. 2011;36(2):173–181.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Coffey C, Carlin JB, Moran P, Patton GC. Who are the new amphetamine users? A 10-year prospective study of young Australians. Addiction. 2007;102(8):1269–1279.
   PubMed Web of Science ®Google Scholar
• Briere FN, Fallu JS, Janosz M, Pagani LS. Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students. J Epidemiol Community Health. 2012;66(11):990–994.
   PubMed Web of Science ®Google Scholar
• Jernigan TL, Gamst AC, Archibald SL, et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry. 2005;162(8):1461–1472.
   PubMed Web of Science ®Google Scholar
• Whittle S, Lichter R, Dennison M, et al. Structural brain development and depression onset during adolescence: a prospective longitudinal study. Am J Psychiatry. 2014;171(5):564–571.
   PubMed Web of Science ®Google Scholar
• Zorick T, Nestor L, Miotto K, et al. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction. 2010;105(10):1809–1818.
   PubMed Web of Science ®Google Scholar
• Takamatsu Y, Yamamoto H, Ogai Y, Hagino Y, Markou A, Ikeda K. Fluoxetine as a potential pharmacotherapy for methamphetamine dependence: studies in mice. Ann N Y Acad Sci. 2006;1074(1):295–302.
   PubMedGoogle Scholar
• Rothman RB, Partilla JS, Dersch CM, Carroll FI, Rice KC, Baumann MH. Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction. Ann N Y Acad Sci. 2000;914(1):71–81.
   PubMedGoogle Scholar
• Rahmani S, Ahmadi S, Hassanian-Moghaddam H. Serotonin syndrome following single ingestion of high dose methamphetamine. Clin Toxicol. 2011;1(3):1000111.
   Google Scholar
• Shoptaw S, Huber A, Peck J, et al. Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2006;85(1):12–18.
   PubMed Web of Science ®Google Scholar
• Braunwarth W-D, Christ M, Dirks H, et al. S3 practice guideline methamphetamine-related disorders. https://www.aezq.de/mdb/edocs/pdf/literatur/s3-gl-methamphetamine-related-disorders-long.pdf. Published 2016.
   Google Scholar
• Rawson RA, Chudzynski J, Gonzales R, et al. The impact of exercise on depression and anxiety symptoms among abstinent methamphetamine-dependent individuals in a residential treatment setting. J Subst Abuse Treat. 2015;57:36–40.
   PubMed Web of Science ®Google Scholar
• Rawson RA, Chudzynski J, Mooney L, et al. Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care. Drug Alcohol Depend. 2015;156:21–28.
   PubMed Web of Science ®Google Scholar
• Nock NL, Minnes S, Alberts JL. Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders. Birth Defects Res. 2017;109(20):1711–1729.
   PubMedGoogle Scholar
• Pisetsky EM, Chao YM, Dierker LC, May AM, Striegel-Moore RH. Disordered eating and substance use in high-school students: results from the Youth Risk Behavior Surveillance System. Int J Eat Disord. 2008;41(5):464–470.
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, et al. Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment. Eat Disord. 2011;19(3):259–269.
   PubMedGoogle Scholar
• Bruening AB, Perez M, Ohrt TK. Exploring weight control as motivation for illicit stimulant use. Eat Behav. 2018;30:72–75.
   PubMed Web of Science ®Google Scholar
• Dawe S, Loxton NJ. The role of impulsivity in the development of substance use and eating disorders. Neurosci Biobehav Rev. 2004;28(3):343–351.
   PubMed Web of Science ®Google Scholar
• Gordon A. Chapter 9. Eating disorders and substance use. In: Department of Health, ed. Adelaide, Australia: Australian Government; 2008.
   Google Scholar
• Uhlmann S, DeBeck K, Simo A, Kerr T, Montaner JSG, Wood E. Health and social harms associated with crystal methamphetamine use among street-involved youth in a Canadian setting. Am J Addict. 2014;23(4):393–398.
   PubMed Web of Science ®Google Scholar
• Hawke JM, Jainchill N, Leon GD. Adolescent amphetamine users in treatment: client profiles and treatment outcomes. J Psychoactive Drugs. 2000;32(1):95–105.
   PubMed Web of Science ®Google Scholar
• Basedow LA, Kuitunen-Paul S, Roessner V, Golub Y. Traumatic events and substance use disorders in adolescents. Front Psychiatry. 2020;11:559.
   PubMed Web of Science ®Google Scholar
• Lopez-Patton M, Kumar M, Jones D, Fonseca M, Kumar AM, Nemeroff CB. Childhood trauma and METH abuse among men who have sex with men: implications for intervention. J Psychiatr Res. 2016;72:1–5.
   PubMed Web of Science ®Google Scholar
• Maxwell JC. A new survey of methamphetamine users in treatment: who they are, why they like “meth,” and why they need additional services. Subst Use Misuse. 2014;49(6):639–644.
   PubMed Web of Science ®Google Scholar
• Argento E, Strathdee SA, Goldenberg S, Braschel M, Montaner J, Shannon K. Violence, trauma and living with HIV: longitudinal predictors of initiating crystal methamphetamine injection among sex workers. Drug Alcohol Depend. 2017;175:198–204.
   PubMed Web of Science ®Google Scholar
• Svingen L, Dykstra RE, Simpson JL, et al. Associations between family history of substance use, childhood trauma, and age of first drug use in persons with methamphetamine dependence. J Addict Med. 2016;10(4):269–273.
   PubMed Web of Science ®Google Scholar
• Smith RC, Blumenthal H, Badour C, Feldner MT. An investigation of relations between crystal methamphetamine use and posttraumatic stress disorder. Addict Behav. 2010;35(6):625–627.
   PubMed Web of Science ®Google Scholar
• Schäfer I, Lotzin A, Milin S. Ungedeckte psychotherapeutische Bedarfe bei Stimulanzienkonsumenten. Psychotherapeut. 2014;59(4):300–305.
   Google Scholar
• Hsieh JH, Stein DJ, Howells FM. The neurobiology of methamphetamine induced psychosis. Front Hum Neurosci. 2014;8:537–537.
   PubMed Web of Science ®Google Scholar
• Hall W, Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug Alcohol Rev. 1994;13(3):277–284.
   PubMedGoogle Scholar
• Grant KM, Kelley SS, Agrawal S, Meza JL, Meyer JR, Romberger DJ. Methamphetamine use in rural Midwesterners. Am J Addict. 2007;16(2):79–84.
   PubMed Web of Science ®Google Scholar
• Leamon MH, Flower K, Salo RE, Nordahl TE, Kranzler HR, Galloway GP. Methamphetamine and paranoia: the methamphetamine experience questionnaire. Am J Addict. 2010;19(2):155–168.
   PubMed Web of Science ®Google Scholar
• Harris DS, Boxenbaum H, Everhart ET, Sequeira G, Mendelson JE, Jones RT. The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther. 2003;74(5):475–486.
   PubMed Web of Science ®Google Scholar
• Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W. Methamphetamine abstinence syndrome: preliminary findings. Am J Addict. 2004;13(3):248–255.
   PubMed Web of Science ®Google Scholar
• Lago JA, Kosten TR. Stimulant withdrawal. Addiction. 1994;89(11):1477–1481.
   PubMed Web of Science ®Google Scholar
• McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction. 2006;101(10):1473–1478.
   PubMed Web of Science ®Google Scholar
• Lecomte T, Dumais A, Dugre JR, Potvin S. The prevalence of substance-induced psychotic disorder in methamphetamine misusers: a meta-analysis. Psychiatry Res. 2018;268:189–192.
   PubMed Web of Science ®Google Scholar
• Lappin JM, Sara GE. Psychostimulant use and the brain. Addiction. 2019;114(11):2065–2077.
   PubMed Web of Science ®Google Scholar
• Cederlöf M, Kuja-Halkola R, Larsson H, et al. A longitudinal study of adolescent psychotic experiences and later development of substance use disorder and suicidal behavior. Schizophr Res. 2017;181:13–16.
   PubMed Web of Science ®Google Scholar
• Dhossche D, Ferdinand R, Van Der Ende J, Hofstra MB, Verhulst F. Diagnostic outcome of self-reported hallucinations in a community sample of adolescents. Psychol Med. 2002;32(4):619–627.
   PubMed Web of Science ®Google Scholar
• Starzer MSK, Nordentoft M, Hjorthøj C. Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis. Am J Psychiatry. 2018;175(4):343–350.
   PubMed Web of Science ®Google Scholar
• Wodarz N, Krampe-Scheidler A, Christ M, et al. Evidence-based guidelines for the pharmacological management of acute methamphetamine-related disorders and toxicity. Pharmacopsychiatry. 2017;50(3):87–95.
   PubMed Web of Science ®Google Scholar
• Fonagy P, Speranza M, Luyten P, Kaess M, Hessels C, Bohus M. ESCAP expert article: borderline personality disorder in adolescence: an expert research review with implications for clinical practice. Eur Child Adolesc Psychiatry. 2015;24(11):1307–1320.
   PubMed Web of Science ®Google Scholar
• Cohen P, Chen H, Crawford TN, Brook JS, Gordon K. Personality disorders in early adolescence and the development of later substance use disorders in the general population. Drug Alcohol Depend. 2007;88(Suppl 1):S71–S84.
   PubMed Web of Science ®Google Scholar
• Trull TJ, Freeman LK, Vebares TJ, Choate AM, Helle AC, Wycoff AM. Borderline personality disorder and substance use disorders: an updated review. Bord Personal Disord Emot Dysregul. 2018;5(1):15.
   PubMedGoogle Scholar
• Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised Nesarc personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010;24(4):412–426.
   PubMed Web of Science ®Google Scholar
• Scalzo F, Hulbert CA, Betts JK, Cotton SM, Chanen AM. Predictors of substance use in youth with borderline personality disorder. Personal Disord. 2018;9(4):390–396.
   PubMedGoogle Scholar
• Zhang C, Luo T, Liu L, Dong H, Hao W. Prevalence rates of personality disorder and its association with methamphetamine dependence in compulsory treatment facilities in China. Front Psychiatry. 2018;9:698.
   PubMed Web of Science ®Google Scholar
• Eslami-Shahrbabaki M, Fekrat A, Mazhari S. A study of the prevalence of psychiatric disorders in patients with methamphetamine-induced psychosis. Addict Health. 2015;7(1–2):37–46.
   PubMedGoogle Scholar
• Fenton MC, Keyes K, Geier T, et al. Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction. 2012;107(3):599–609.
   PubMed Web of Science ®Google Scholar
• Kienast T, Roediger E, Kensche M, Foerster J, Daig I, Heinz A. Evidence-based psychotherapy: addiction and personality disorders as comorbidities. Nervenarzt. 2009;80(9):1050–1059.
   PubMedGoogle Scholar
• Rizvi SL, Linehan MM. Dialectical behavior therapy for personality disorders. Curr Psychiatry Rep. 2001;3(1):64–69.
   PubMedGoogle Scholar
• Dimeff LA, Linehan MM. Dialectical behavior therapy for substance abusers. Addict Sci Clin Pract. 2008;4(2):39–47.
   PubMedGoogle Scholar
• Embry D, Hankins M, Biglan A, Boles S. Behavioral and social correlates of methamphetamine use in a population-based sample of early and later adolescents. Addict Behav. 2009;34(4):343–351.
   PubMed Web of Science ®Google Scholar
• Fletcher JB, Swendeman D, Reback CJ. Mental health and substance use disorder comorbidity among methamphetamine-using men who have sex with men. J Psychoactive Drugs. 2018;50(3):206–213.
   PubMed Web of Science ®Google Scholar
• Saban A, Flisher A, Laubscher R, London L, Morojele N. The association between psychopathology and substance use: adolescent and young adult substance users in inpatient treatment in Cape Town, South Africa. Pan Afr Med J. 2014;17 (Suppl 1(Suppl 1):8–8.
   PubMedGoogle Scholar
• Rungnirundorn T, Verachai V, Gelernter J, Malison RT, Kalayasiri R. Sex differences in methamphetamine use and dependence in a Thai treatment center. J Addict Med. 2017;11(1):19–27.
   PubMed Web of Science ®Google Scholar
• Fletcher JB, Reback CJ. Antisocial personality disorder predicts methamphetamine treatment outcomes in homeless, substance-dependent men who have sex with men. J Subst Abuse Treat. 2013;45(3):266–272.
   PubMed Web of Science ®Google Scholar
• Fazel S, Danesh J. Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys. Lancet. 2002;359(9306):545–550.
   PubMed Web of Science ®Google Scholar
• Kramer TL, Han X, Leukefeld C, Booth BM, Edlund C. Childhood conduct problems and other early risk factors in rural adult stimulant users. J Rural Health. 2009;25(1):50–57.
   PubMed Web of Science ®Google Scholar
• Office of the Surgeon General (US), National Center for Injury Prevention and Control (US), National Institute of Mental Health (US) and Center for Mental Health Services (US). Chapter 5 – prevention and intervention. Youth Violence: A Report of the Surgeon General. Rockville, MD: Office of the Surgeon General (US); 2001.
   Google Scholar
• Dhein S, Schmelmer K, Guenther J, Salameh A. Aspects of methamphetamine abuse in adolescents and young adults in a Thuringian County. Eur Addict Res. 2018;24(2):98–105.
   PubMed Web of Science ®Google Scholar
• Barrett SP, Darredeau C, Pihl RO. Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol Clin Exp. 2006;21(4):255–263.
   PubMed Web of Science ®Google Scholar
• McKetin R, Lubman DI, Lee NM, Ross JE, Slade TN. Major depression among methamphetamine users entering drug treatment programs. Med J Aust. 2011;195(3):S51–S55.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101(4):556–569.
   PubMed Web of Science ®Google Scholar
• Cuzen NL, Koopowitz SM, Ferrett HL, Stein DJ, Yurgelun-Todd D. Methamphetamine and cannabis abuse in adolescence: a quasi-experimental study on specific and long-term neurocognitive effects. BMJ Open. 2015;5(1):e005833–e005833.
   PubMed Web of Science ®Google Scholar
• Mendelson J, Jones RT, Upton R, Jacob P. 3rd. Methamphetamine and ethanol interactions in humans. Clin Pharmacol Ther. 1995;57(5):559–568.
   PubMed Web of Science ®Google Scholar
• Albertson TE, Derlet RW, Van Hoozen BE. Methamphetamine and the expanding complications of amphetamines. West J Med. 1999;170(4):214–219.
   PubMedGoogle Scholar
• Mitra G, Wood E, Nguyen P, Kerr T, DeBeck K. Drug use patterns predict risk of non-fatal overdose among street-involved youth in a Canadian setting. Drug Alcohol Depend. 2015;153:135–139.
   PubMed Web of Science ®Google Scholar
• Spear LP. Consequences of adolescent use of alcohol and other drugs: studies using rodent models. Neurosci Biobehav Rev. 2016;70:228–243.
   PubMed Web of Science ®Google Scholar
• Chomchai C, Chomchai S. Global patterns of methamphetamine use. Curr Opin Psychiatry. 2015;28(4):269–274.
   PubMed Web of Science ®Google Scholar
• Basedow LA, Kuitunen-Paul S, Roessner V, Golub Y. Trauma und PTBS in jugendlichen Patienten mit einer Substanzkonsumstörung. Suchttherapie. 2019;20(S 01):P12.
   Google Scholar
• Girelli G. The death penalty for drug offences: global overview 2018. In: Harm Reduction International, ed. London, UK: Harm Reduction International; 2019.
   Google Scholar
• Mackey S, Allgaier N, Chaarani B, et al. Mega-analysis of gray matter volume in substance dependence: general and substance-specific regional effects. Am J Psychiatry. 2019;176(2):119–128.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Usui H, Takahashi N, et al. Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(5):1268–1272.
   PubMed Web of Science ®Google Scholar
• Kotyuk E, Nemeth N, Ronai Z, Demetrovics Z, Sasvari-Szekely M, Szekely A. Association between smoking behaviour and genetic variants of glial cell line-derived neurotrophic factor. J Genet. 2016;95(4):811–818.
   PubMed Web of Science ®Google Scholar
• Chen CK, Lin SK, Sham PC, Ball D, Loh EW, Murray RM. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet. 2005;136b(1):87–91.
   PubMed Web of Science ®Google Scholar
• Breen MS, Uhlmann A, Ozcan S, et al. Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis. Sci Rep. 2017;7:43777.
   PubMed Web of Science ®Google Scholar
• Grant KM, LeVan TD, Wells SM, et al. Methamphetamine-associated psychosis. J Neuroimmune Pharmacol. 2012;7(1):113–139.
   PubMed Web of Science ®Google Scholar
• Bramness JG, Rognli EB. Psychosis induced by amphetamines. Curr Opin Psychiatry. 2016;29(4):236–241.
   PubMed Web of Science ®Google Scholar
• Crouse JJ, Lee RSC, White D, Moustafa AA, Hickie IB, Hermens DF. Distress and sleep quality in young amphetamine-type stimulant users with an affective or psychotic illness. Psychiatry Res. 2018;262:254–261.
   PubMed Web of Science ®Google Scholar
• Chang L, Alicata D, Ernst T, Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction. 2007;102(s1):16–32.
   PubMedGoogle Scholar
• Vuletic D, Dupont P, Robertson F, Warwick J, Zeevaart JR, Stein DJ. Methamphetamine dependence with and without psychotic symptoms: a multi-modal brain imaging study. Neuroimage Clin. 2018;20:1157–1162.
   PubMed Web of Science ®Google Scholar
• Thirthalli J, Benegal V. Psychosis among substance users. Curr Opin Psychiatry. 2006;19(3):239–245.
   PubMed Web of Science ®Google Scholar
• Egan MF, Weinberger DR. Neurobiology of schizophrenia. Curr Opin Neurobiol. 1997;7(5):701–707.
   PubMed Web of Science ®Google Scholar
• Markou A, Kenny PJ. Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotox Res. 2002;4(4):297–313.
   PubMed Web of Science ®Google Scholar
• Bananej A, Volkl-Kernstock S, Lesch O, Walter H, Skala K. No evidence of subgroups found in amphetamine consumers in Iran. Neuropsychiatr. 2018;32(2):69–74.
   PubMed Web of Science ®Google Scholar
• Al-Tayyib A, Koester S, Langegger S, Raville L. Heroin and methamphetamine injection: an emerging drug use pattern. Subst Use Misuse. 2017;52(8):1051–1058.
   PubMed Web of Science ®Google Scholar
• Furr CDM, Delva J, Anthony JC. The suspected association between methamphetamine ('ice') smoking and frequent episodes of alcohol intoxication: data from the 1993 National Household Survey on Drug Abuse. Drug Alcohol Depend. 2000;59(1):89–93.
   PubMed Web of Science ®Google Scholar
• Bujarski S, Roche DJ, Lunny K, et al. The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. Drug Alcohol Depend. 2014;142:127–132.
   PubMed Web of Science ®Google Scholar
• Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophr Bull. 2000;26(1):105–118.
   PubMed Web of Science ®Google Scholar
• Jaffe C, Bush KR, Straits-Troster K, et al. A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology. J Addict Dis. 2005;24(3):133–152.
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, et al. Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. Am J Addict. 2010;19(5):385–390.
   PubMed Web of Science ®Google Scholar
• Verheul R, Kranzler HR, Poling J, Tennen H, Ball S, Rounsaville BJ. Axis I and Axis II disorders in alcoholics and drug addicts: fact or artifact? J Stud Alcohol. 2000;61(1):101–110.
   PubMed Web of Science ®Google Scholar
• Kobayashi O, Matsumoto T, Otsuki M, et al. Profiles associated with treatment retention in Japanese patients with methamphetamine use disorder: preliminary survey. Psychiatry Clin Neurosci. 2008;62(5):526–532.
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards S, Mooney LJ, Ang A, Hillhouse M, Rawson R. Does Posttraumatic Stress Disorder (PTSD) affect post-treatment methamphetamine use? J Dual Diagn. 2013;9(2):123–128.
   PubMed Web of Science ®Google Scholar
• Gilder DA, Gizer IR, Lau P, Ehlers CL. Stimulant dependence and stimulant-associated psychosis: clinical characteristics and age of onset in a Native American community sample. J Addict Med. 2014;8(4):241–248.
   PubMed Web of Science ®Google Scholar
• Niemi-Pynttäri J, Sund R, Putkonen H, Vorma H, Wahlbeck K, Pirkola S. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases. J Clin Psychiatry. 2013;74(1):e94–e99.
   PubMed Web of Science ®Google Scholar
• Hellem TL, Sung YH, Shi XF, et al. Creatine as a novel treatment for depression in females using methamphetamine: a pilot study. J Dual Diagn. 2015;11(3–4):189–202.
   PubMed Web of Science ®Google Scholar
• Rawson RA, Shoptaw SJ, Obert JL, et al. An intensive outpatient approach for cocaine abuse treatment: the matrix model. J Subst Abuse Treat. 1995;12(2):117–127.
   PubMed Web of Science ®Google Scholar
• Obert JL, McCann MJ, Martinez J. The Matrix Model for Teens and Young Adults. Therapist's Manual. 2nd ed., revised and expanded update to meet DSM-5 classifications ed. Center City, MN: Hazelden; 2017.
   Google Scholar
• Argento E, Strathdee SA, Tupper K, Braschel M, Wood E, Shannon K. Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting. BMJ Open. 2017;7(9):e016025
   PubMed Web of Science ®Google Scholar
• Voss C, Ollmann TM, Miché M, et al. Prevalence, onset, and course of suicidal behavior among adolescents and young adults in Germany. JAMA Netw Open. 2019;2(10):e1914386.
   PubMed Web of Science ®Google Scholar
• Canadian Paediatric Society. Position statement. Age limits and adolescents. Paediatr Child Health. 2003;8(9):577–578.
   PubMedGoogle Scholar
• van Loo HM, Romeijn J-W. Psychiatric comorbidity: fact or artifact? Theor Med Bioeth. 2015;36(1):41–60.
   PubMed Web of Science ®Google Scholar
• Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. 2014;143:11–21.
   PubMed Web of Science ®Google Scholar
• Robins LN, Cottler LB, Bucholz KK, Compton WM, North CS, Rourke KM. Diagnostic Interview Schedule for DSM IV. St. Louis, MI: Washington University in St. Louis; 2002.
   Google Scholar
• Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11(1):22–31.
   PubMed Web of Science ®Google Scholar
• Goldberg DP, Williams P. A Users’ Guide to the General Health Questionnaire. London, UK: GL Assessment; 1988.
   Google Scholar
• Orvaschel H. Schizophrenia and Affective Disorders Schedule for Children—Epidemiological Version (KSADS-E). Unpublished manuscript. Nova University; 1995.
   Google Scholar
• Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale–preliminary report. Psychopharmacol Bull. 1973;9(1):13–28.
   PubMedGoogle Scholar
• Steinberg AM, Brymer MJ, Kim S, et al. Psychometric properties of the UCLA PTSD reaction index: part I. J Trauma Stress. 2013;26(1):1–9.
   PubMed Web of Science ®Google Scholar
• Ibanez GE, Purcell DW, Stall R, Parsons JT, Gomez CA. Sexual risk, substance use, and psychological distress in HIV-positive gay and bisexual men who also inject drugs. Aids. 2005;19(Suppl 1):S49–S55.
   PubMedGoogle Scholar